Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Bn201
2. Privosegtor
3. 1361200-34-1
4. Kcn37l7eih
5. Unii-kcn37l7eih
6. Ocs-05
7. Glycinamide, N-(2-(2-fluorophenyl)ethyl)glycyl-n-(2-methylpropyl)glycyl-n2-(3-(2-oxo-1-pyrrolidinyl)propyl)-
8. N-[2-[(2-amino-2-oxoethyl)-[3-(2-oxopyrrolidin-1-yl)propyl]amino]-2-oxoethyl]-2-[2-(2-fluorophenyl)ethylamino]-n-(2-methylpropyl)acetamide
9. N-(2-((2-amino-2-oxoethyl)-(3-(2-oxopyrrolidin-1-yl)propyl)amino)-2-oxoethyl)-2-(2-(2-fluorophenyl)ethylamino)-n-(2-methylpropyl)acetamide
10. N-(2-amino-2-oxoethyl)-2-(2-((4-fluorophenethyl)amino)-n-isobutylacetamido)-n-(3-(2-oxopyrrolidin-1-yl)propyl)acetamide N-((carbamoylmethyl-(3-(2-oxo-pyrrolidin-1-yl)propyl)-carbamoyl)-methyl)-2-(2-(2-fluorophenyl)-ethylamino)-n-isobutyl-acetamide
11. N-(2-amino-2-oxoethyl)-2-(2-((4-fluorophenethyl)amino)-n-isobutylacetamido)-n-(3-(2-oxopyrrolidin-1-yl)propyl)acetamide N-({carbamoylmethyl-[3-(2-oxo-pyrrolidin-1-yl)propyl}-carbamoyl}-methyl)-2-[2-(2-fluorophenyl)-ethylamino]-n-isobutyl-acetamide
12. Privosegtor [inn]
13. Schembl164347
14. Gtpl13222
15. Glxc-20781
16. Akos040741398
17. Ncgc00476166-01
18. Da-61781
19. G-79
20. Hy-135749
21. Cs-0113924
22. N-(2-amino-2-oxoethyl)-2-(2-((2-fluorophenethyl)amino)-n-isobutylacetamido)-n-(3-(2-oxopyrrolidin-1-yl)propyl)acetamide
23. N-[2-(2-fluorophenyl)ethyl]glycyl-n-(2-methylpropyl)glycyl-n2-[3-(2-oxo-1-pyrrolidinyl)propyl]glycinamide
24. N-[2-(2-fluorophenyl)ethyl]glycyl-n-(2-methylpropyl)glycyl-n2-[3-(2-oxopyrrolidin-1-yl)propyl]glycinamide
| Molecular Weight | 491.6 g/mol |
|---|---|
| Molecular Formula | C25H38FN5O4 |
| XLogP3 | 1.1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 15 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 116 |
| Heavy Atom Count | 35 |
| Formal Charge | 0 |
| Complexity | 720 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
33
PharmaCompass offers a list of Privosegtor API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Privosegtor manufacturer or Privosegtor supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Privosegtor manufacturer or Privosegtor supplier.
PharmaCompass also assists you with knowing the Privosegtor API Price utilized in the formulation of products. Privosegtor API Price is not always fixed or binding as the Privosegtor Price is obtained through a variety of data sources. The Privosegtor Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Privosegtor manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Privosegtor, including repackagers and relabelers. The FDA regulates Privosegtor manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Privosegtor API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Privosegtor supplier is an individual or a company that provides Privosegtor active pharmaceutical ingredient (API) or Privosegtor finished formulations upon request. The Privosegtor suppliers may include Privosegtor API manufacturers, exporters, distributors and traders.
Privosegtor Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Privosegtor GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Privosegtor GMP manufacturer or Privosegtor GMP API supplier for your needs.
A Privosegtor CoA (Certificate of Analysis) is a formal document that attests to Privosegtor's compliance with Privosegtor specifications and serves as a tool for batch-level quality control.
Privosegtor CoA mostly includes findings from lab analyses of a specific batch. For each Privosegtor CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Privosegtor may be tested according to a variety of international standards, such as European Pharmacopoeia (Privosegtor EP), Privosegtor JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Privosegtor USP).
